Acadian Asset Management LLC Rubius Therapeutics, Inc. Transaction History

Acadian Asset Management LLC

  • $32.2 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 11, 2023
SELL
$0.02 - $0.34 $21,950 - $373,156
-1,097,520 Reduced 85.93%
179,676 $2,000
Q4 2022

Feb 14, 2023
BUY
$0.14 - $0.31 $86,033 - $190,501
614,522 Added 92.73%
1,277,196 $222,000
Q3 2022

Nov 14, 2022
BUY
$0.46 - $1.29 $118,370 - $331,951
257,327 Added 63.48%
662,674 $286,000
Q2 2022

Aug 09, 2022
BUY
$0.79 - $5.98 $320,224 - $2.42 Million
405,347 New
405,347 $345,000

Others Institutions Holding RUBY

# of Institutions
2
Shares Held
325
Call Options Held
0
Put Options Held
0
View Full List

About Rubius Therapeutics, Inc.

RUBY Quotes by TradingView
  • Ticker RUBY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 90,357,000
  • Description
  • Rubius Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of red cell therapeutics (RCTs) for the treatment of patients with severe diseases. The company is developing RTX-240 and RTX-224 for the treatment of solid tumors cancer; and RTX-aAPC to treat cancers. It is also developing RTX-321 for the treatmen...
More about RUBY
Track This Portfolio

Track Acadian Asset Management LLC Portfolio

Follow Acadian Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Acadian Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Acadian Asset Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email